XML 33 R12.htm IDEA: XBRL DOCUMENT
v3.25.2

MARKETABLE SECURITIES | 6 Months Ended
--- | ---
Jun. 30, 2025
MARKETABLE SECURITIES |
MARKETABLE SECURITIES | 5. MARKETABLE SECURITIES: Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at June 30, 2025, were as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amortized | ​ | Gross Unrealized | ​ | Estimated Fair
(In thousands) |  | Cost |  | Gains |  | Losses |  | Market Value
Investments due in 3 months or less: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Corporate securities | ​ | $ | 15,661 | ​ | $ | 7 | ​ | $ | (10) | ​ | $ | 15,658
Total | ​ |  | 15,661 | ​ |  | 7 | ​ |  | (10) | ​ |  | 15,658
Investments due in 4-12 months: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ | ​ | 25,976 | ​ | ​ | 94 | ​ | ​ | (6) | ​ | ​ | 26,064
Total | ​ |  | 25,976 | ​ |  | 94 | ​ |  | (6) | ​ |  | 26,064
Investments due in 12 months or greater: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ |  | 158,421 | ​ |  | 1,663 | ​ |  | (5) | ​ |  | 160,079
Total | ​ | ​ | 158,421 | ​ |  | 1,663 | ​ | ​ | (5) | ​ |  | 160,079
Total marketable securities | ​ | $ | 200,058 | ​ | $ | 1,764 | ​ | $ | (21) | ​ | $ | 201,801
​ Accrued interest receivable was $2.5 million at June 30, 2025 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet. Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2024, were as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amortized | ​ | Gross Unrealized | ​ | Estimated Fair
(In thousands) |  | Cost |  | Gains |  | Losses |  | Market Value
Investments due in 3 months or less: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Corporate securities | ​ | $ | 10,972 | ​ | $ | 4 | ​ | $ | (3) | ​ | $ | 10,973
Total | ​ |  | 10,972 | ​ |  | 4 | ​ |  | (3) | ​ |  | 10,973
Investments due in 4-12 months: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ |  | 87,346 | ​ |  | 159 | ​ |  | (19) | ​ |  | 87,486
Total | ​ |  | 87,346 | ​ |  | 159 | ​ |  | (19) | ​ |  | 87,486
Investments due in 12 months or greater: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ | ​ | 149,817 | ​ |  | 860 | ​ |  | (113) | ​ |  | 150,564
Total | ​ |  | 149,817 | ​ |  | 860 | ​ |  | (113) | ​ |  | 150,564
Total marketable securities | ​ | $ | 248,135 | ​ | $ | 1,023 | ​ | $ | (135) | ​ | $ | 249,023
​ Accrued interest receivable was $2.8 million at December 31, 2024 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet. The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was not recorded at June 30, 2025:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Less Than 12 Months | ​ | 12 Months or Longer | ​ | Total
​ |  | Estimated |  | Gross |  | Estimated |  | Gross |  | Estimated |  | Gross
​ | ​ | Fair Market | ​ | Unrealized | ​ | Fair Market | ​ | Unrealized | ​ | Fair Market | ​ | Unrealized
(In thousands) | ​ | Value | ​ | Losses | ​ | Value | ​ | Losses | ​ | Value | ​ | Losses
Corporate securities | ​ | $ | 9,205 | ​ | $ | (17) | ​ | $ | 2,925 | ​ | $ | (4) | ​ | $ | 12,130 | ​ | $ | (21)
Total marketable securities | ​ | $ | 9,205 | ​ | $ | (17) | ​ | $ | 2,925 | ​ | $ | (4) | ​ | $ | 12,130 | ​ | $ | (21)
​ In the three and six months ended June 30, 2025 and 2024, no unrealized losses on marketable securities were recognized in income. The Company does not intend to sell and it is unlikely that it will be required to sell the securities held prior to their anticipated recovery. The issuers are high quality (investment grade) and the decline in fair value is largely due to changes in interest rates. Additionally, the issuers continue to make timely interest payments on the marketable securities with the fair value expected to recover as they reach maturity.

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/940-320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph b -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration